Journal of Medical Economics
Volume 25, 2022 - Issue 1
Open access
1,461
Views
0
CrossRef citations to date
0
Altmetric
Oncology
The impact of remission duration on the long-term economic burden of acute myeloid leukemia among patients without hematopoietic stem cell transplant in the United States
Ashley Tabaha Bristol Myers Squibb, Princeton, NJ, USAhttps://orcid.org/0000-0003-3754-2703
, Brenna L. Bradyb IBM Watson Health, Cambridge, MA, USACorrespondence[email protected]
https://orcid.org/0000-0003-3210-806X
, https://orcid.org/0000-0003-3210-806X
David Huggara Bristol Myers Squibb, Princeton, NJ, USAhttps://orcid.org/0000-0002-9037-8140
, Krutika Jariwala-Parikhb IBM Watson Health, Cambridge, MA, USA
, Krystal Hueya Bristol Myers Squibb, Princeton, NJ, USA
, Ronda Cophera Bristol Myers Squibb, Princeton, NJ, USA
& Thomas William LeBlancc Duke Cancer Institute, Durham, NC, USAhttps://orcid.org/0000-0002-0546-7895
show all
Pages 903-911
|
Received 02 Feb 2022, Accepted 16 Jun 2022, Published online: 04 Jul 2022
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.